Supernus Pharm
(SUPN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 392,755 | 408,897 | 302,238 | 215,003 | 147,465 |
| Cost of Goods | 16,660 | 15,356 | 15,215 | 11,986 | 8,423 |
| Gross Profit | 376,095 | 393,541 | 287,023 | 203,017 | 139,042 |
| Operating Expenses | 228,184 | 249,453 | 187,697 | 149,787 | 118,621 |
| Operating Income | 148,571 | 144,444 | 99,541 | 54,216 | 20,844 |
| Interest Expense | 22,707 | 18,111 | 1,568 | 5,091 | 4,770 |
| Other Income | 21,623 | 13,843 | 2,645 | 1,244 | -1,464 |
| Pre-tax Income | 147,487 | 140,176 | 100,618 | 50,369 | 14,610 |
| Income Tax | 34,431 | 29,183 | 43,334 | -40,852 | 666 |
| Net Income Continuous | 113,056 | 110,993 | 57,284 | 91,221 | 13,944 |
| Net Income | $113,056 | $110,993 | $57,284 | $91,221 | $13,944 |
| EPS Basic Total Ops | 2.16 | 2.13 | 1.13 | 1.84 | 0.29 |
| EPS Basic Continuous Ops | 2.16 | 2.13 | 1.13 | 1.84 | 0.29 |
| EPS Diluted Total Ops | 2.10 | 2.05 | 1.08 | 1.76 | 0.28 |
| EPS Diluted Continuous Ops | 2.10 | 2.05 | 1.07 | 1.76 | 0.27 |
| EPS Diluted Before Non-Recurring Items | 2.10 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $166,904 | $161,690 | $107,160 | $57,135 | $22,513 |